診療部‐2017年 論文 

論文・執筆名 著者 共同発表者名 論文・書籍名等 出版社名等 発行年 号数等 巻号頁
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab. Nishimura R Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K. Oncology KARGER 2017 93(1) 51-61
The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy Tanaka K Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y. Breast Cancer Springer 2017 24(3) 384-392
Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. Wong SM Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M. Cancer Wiley 2017 123(14) 2609-2617
Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma Kikuchi K McNamara KM, Miki Y, Moon JY, Choi MH, Omata F, Sakurai M, Onodera Y, Rai Y, Ohi Y, Sagara Y, Miyashita M, Ishida T, Ohuchi N, Sasano H. Breast Cancer Research and Treatment Springer 2017 166(3) 709-723
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast Sagara Y Julia W, Golshan M, Toi M. Frontiers in Oncology Frontiers Media SA 2017 Publis hed online
Trends in adjuvant therapies after breast-conserving surgery for hormone receptorpositive ductal carcinoma in situ : findings from the National Cancer Database, 2004-2013 Yasuaki Sagara Rachel A. Freedman, Stephanie M. Wong, Faitih Aydogan, Anvy Nguyen, William T.Barry, Mehra Golshan. Breast Cancer Research and Treatment Springer 2017 166(2) 583-592